新一代抗癌药物相关的生育与生殖担忧及其对接受实体瘤治疗的年轻患者的临床意义
本综述汇总了免疫检查点抑制剂、抗体药物偶联物、小分子及单克隆抗体靶向治疗等新型疗法对生育力、妊娠和哺乳影响的现有认知,并讨论了黑色素瘤、肺癌、乳腺癌、结直肠癌和妇科肿瘤等已广泛引入新疗法的患者群体的生殖担忧,指出需提高对药物生殖组织毒性的认识,并基于现有专业知识和可用的生育力保存方法告知患者。
要点
- 新型靶向和免疫治疗在多种癌症中降低复发风险并延长生存,但对其生育力、妊娠和哺乳的影响存在很大不确定性。
- 携带可靶向分子改变或突变的肿瘤患者常较年轻,未来生育和家庭构建可能是重要担忧。
- 需提高对药物生殖组织潜在毒性的认识,并基于现有专业知识和可用生育力保存方法告知患者。
核心结论
- 需提高对新型抗癌药物潜在生殖组织毒性的认识,并基于现有专业知识和可用的生育力保存方法告知患者。
研究设计与样本
- 本综述旨在汇总关于肿瘤生育力与免疫检查点抑制剂、抗体药物偶联物、小分子及单克隆抗体靶向治疗等不同新型疗法的现有知识。
主要发现
- 分子靶向治疗和免疫治疗已在许多癌症中实施,并降低了复发风险、延长了生存。
- 携带特定可靶向分子改变或突变的肿瘤患者常较年轻,未来生育和家庭构建可能是该群体重要担忧。
- 关于新药对生殖功能(包括生育力、妊娠和哺乳)的影响以及如何对年轻男女癌症患者进行建议,存在很大不确定性。
- 综述讨论了黑色素瘤、肺癌、乳腺癌、结直肠癌和妇科肿瘤等已广泛引入新疗法的不同患者群体的具体情况和生殖担忧。
临床怎么用
- 需提高对药物生殖组织潜在毒性的认识,并基于当前专业知识和可用的生育力保存方法告知患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The treatment landscape of solid tumors has changed markedly in the last years. Molecularly targeted treatments and immunotherapies have been implemented and have, in many cancers, lowered the risk of relapse and prolonged survival. Patients with tumors harboring specific targetable molecular alterations or mutations are often of a younger age, and hence future fertility and family building can be important concerns in this group. However, there are great uncertainties regarding the effect of the new drugs on reproductive functions, including fertility, pregnancy and lactation and how young patients with cancers, both women and men should be advised. The goal with this review is to gather the current knowledge regarding oncofertility and the different novel therapies, including immune checkpoint inhibitors, antibody-drug conjugates, small molecules and monoclonal antibody targeted therapies. The specific circumstances and reproductive concerns in different patient groups where novel treatments have been broadly introduced are also discussed, including those with melanoma, lung, breast, colorectal and gynecological cancers. It is clear, that more awareness is needed regarding potential drug toxicity on reproductive tissues, and it is of essence that individuals are informed based on current expertise and on available fertility preservation methods.
引用
- Helgadottir H, Matikas A, Fernebro J, et al. Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors. Eur J Cancer. 2024. PMID: 38520926. doi:10.1016/j.ejca.2024.114010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。